Moderna Vaccine Triggers Robust Immune Response in Kids: Study Moderna Vaccine Triggers Robust Immune Response in Kids: Study

The vaccine manufacturer released the first data from a phase 2/3 study evaluating immune response and safety in children 6-11 years old.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news